Home › Non-Muscle Invasive Bladder Cancer › Louisiana
Non-Muscle Invasive Bladder Cancer clinical trials in Louisiana
5 studies for Non-Muscle Invasive Bladder Cancer are looking for participants at sites in Louisiana.
Cities in Louisiana
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Mary Bird Perkins Cancer Center - Metairie, Metairie
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07000084A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Southern Urology, LLC ( Site 0145), Lafayette
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06833073A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- Southern Urology LLC, Lafayette
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06919965Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Southern Urology, Lafayette
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT05951179FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Mary Bird Perkins Cancer Center, Baton Rouge
- Ochsner Clinic Foundation, New Orleans
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT05614739From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.